ACETO to Participate at the Deutsche Bank's Small & Mid Cap Conference

Wed Nov 6, 2013 4:00pm EST

* Reuters is not responsible for the content in this press release.

PORT WASHINGTON, N.Y., Nov. 6, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that Albert Eilender, Chairman, is scheduled to participate at the Deutsche Bank Small & Mid Cap Conference on Wednesday, November 20, 2013 in Coral Gables, Florida.

Event: Deutsche Bank's Small & Mid Cap Conference
Date: November 19-20, 2013
Place: The Biltmore Hotel, Coral Gables, Florida

Mr. Eilender will be conducting one-on-one meetings at the conference on November 20, 2013.


ACETO Corporation, incorporated in 1947, is a global leader in the marketing, sale and distribution of products for Human Health (finished dosage form generics and nutraceutical products), Pharmaceutical Ingredients (pharmaceutical intermediates and active pharmaceutical ingredients) and Performance Chemicals (specialty chemicals and agricultural protection products). With business operations in nine countries, ACETO distributes over 1,100 chemical compounds used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. ACETO's global operations, including a staff of 25 in China and 12 in India, are distinctive in the industry and enable its worldwide sourcing and regulatory capabilities.

CONTACT: Investor Relations Contact:
         Stephanie Carrington/David Burke
         The Ruth Group
         (646) 536-7017/7009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.